- Home
- LEGN vs AXS Comparison
LEGN vs AXS Comparison
Compare LEGN & AXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LEGN | AXS |
|---|---|---|
| Founded | 2014 | 2001 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 8.3B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | LEGN | AXS |
|---|---|---|
| Price | $21.90 | $107.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 8 |
| Target Price | $69.58 | ★ $117.00 |
| AVG Volume (30 Days) | ★ 2.6M | 645.2K |
| Earning Date | 11-12-2025 | 01-28-2026 |
| Dividend Yield | N/A | ★ 1.63% |
| EPS Growth | N/A | ★ 68.27 |
| EPS | N/A | ★ 12.10 |
| Revenue | $909,045,000.00 | ★ $6,301,015,000.00 |
| Revenue This Year | $68.83 | $6.62 |
| Revenue Next Year | $51.27 | $8.64 |
| P/E Ratio | ★ N/A | $8.92 |
| Revenue Growth | ★ 74.75 | 5.59 |
| 52 Week Low | $21.19 | $83.90 |
| 52 Week High | $45.30 | $108.12 |
Technical Indicators
Market Signals| Indicator | LEGN | AXS |
|---|---|---|
| Relative Strength Index (RSI) | 25.47 | 72.72 |
| Support Level | $21.19 | $105.67 |
| Resistance Level | $28.97 | $108.12 |
| Average True Range (ATR) | 1.27 | 1.95 |
| MACD | -0.26 | 0.63 |
| Stochastic Oscillator | 9.13 | 96.35 |
Price Performance
Historical ComparisonAbout LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About AXS Axis Capital Holdings Limited
Axis Capital Holdings Ltd is a specialty underwriter and provider of insurance and reinsurance solutions with operations in Bermuda, the United States ("U.S."), Europe, Singapore, and Canada. The company manages its portfolio holistically, aiming to construct an optimum consolidated portfolio of funded and unfunded risks. The company's segment consists of AXIS Insurance and AXIS Reinsurance. The company generates the majority of its revenue from the Insurance segment. Geographically, the company generates the majority of its revenue from the United States.